Evidence map›Paper›PMID 17553990›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2007

A crucial role for p57(Kip2) in the intracellular timer that controls oligodendrocyte differentiation.

Jason C Dugas, Adiljan Ibrahim, Ben A Barres

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Functional Versatility of the CDK Inhibitor p57Frontiers in cell and developmental biology · 2020
    Review
  7. Article
  8. Article
  9. What does time mean in development?Development (Cambridge, England) · 2018
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Oligodendrocyte Development and Plasticity.Cold Spring Harbor perspectives in biology · 2015
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jason C DugasDepartment of Neurobiology, Stanford University School of Medicine, Stanford, California 94305-5125, USA. jcdugas@alum.mit.edu
Adiljan Ibrahim
Ben A Barres
Stanford University · US

Funding

OPTIC NERVE MYELINATIONR01EY010257 · NEI · STANFORD UNIVERSITY · PI BARRES, BEN A · 1999 to 2012
$4.0M
NEI NIH HHS R01 EY010257NEI NIH HHS R01 EY10257
6 · The paper itself

Abstract

The intracellular molecular mechanism that controls the timing of oligodendrocyte differentiation remains unknown. Temple and Raff (1986) previously showed that an oligodendrocyte precursor cell (OPC) can divide a maximum of approximately eight times before its daughter cells simultaneously cease proliferating and differentiate into oligodendrocytes. They postulated that over time the level of an intracellular molecule might synchronously change in each daughter cell, ultimately reaching a level that prohibited additional proliferation. Here, we report the discovery of such a molecule, the cyclin-dependent kinase inhibitor p57(Kip2) (Cdkn1c). We show in vitro that all daughters of a clone of OPCs express similar levels of p57(Kip2), that p57(Kip2) levels increase over time in proliferating OPCs, and that p57(Kip2) levels regulate how many times an OPC can divide before differentiating. These findings reveal a novel part of the mechanism by which OPCs measure time and are likely to extend to similar timers in many other precursor cell types.

Indexed as

AnimalsAnimals, NewbornBiological ClocksCell DifferentiationCells, CulturedCyclin-Dependent Kinase Inhibitor p57Intracellular FluidMiceOligodendrogliaRatsRats, Sprague-DawleyTime FactorsCyclin-Dependent Kinase Inhibitor p57

Identifiers

PMID17553990
PMCPMC6672145
OpenAlexW2041781614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.